Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Imbalance of CD4+ lymphocyte subsets in patients with mixed connective tissue disease

View through CrossRef
SUMMARYCD4+ (helper/inducer) T lymphocyte subsets were studied in the peripheral blood from patients with mixed connective tissue disease (MCTD) by double-labelling immunofluorescence. The proportion of CD4+CD45RA+ cells was higher (P < 0·01) when compared with controls, whereas CD4+CD29+ cells were markedly diminished (P < 0·001). CD4+CD29+ cells were lower than in patients with progressive systemic sclerosis who were studied in parallel. Upon stimulation with phytohaemagglutinin, CD4+ cells from MCTD patients showed a strong reactivity to acquire the CD29+ phenotype. Expression of high levels of CD29 and other adhesion molecules might lead to facilitated localization of CD4+ cells to inflamed tissue. It is suggested that an increased responsiveness of CD4+ cells to activation signals in vivo and accumulation of CD4+CD29+ cells at tissue sites could result in depletion of this cell subset in the peripheral blood of patients with MCTD.
Title: Imbalance of CD4+ lymphocyte subsets in patients with mixed connective tissue disease
Description:
SUMMARYCD4+ (helper/inducer) T lymphocyte subsets were studied in the peripheral blood from patients with mixed connective tissue disease (MCTD) by double-labelling immunofluorescence.
The proportion of CD4+CD45RA+ cells was higher (P < 0·01) when compared with controls, whereas CD4+CD29+ cells were markedly diminished (P < 0·001).
CD4+CD29+ cells were lower than in patients with progressive systemic sclerosis who were studied in parallel.
Upon stimulation with phytohaemagglutinin, CD4+ cells from MCTD patients showed a strong reactivity to acquire the CD29+ phenotype.
Expression of high levels of CD29 and other adhesion molecules might lead to facilitated localization of CD4+ cells to inflamed tissue.
It is suggested that an increased responsiveness of CD4+ cells to activation signals in vivo and accumulation of CD4+CD29+ cells at tissue sites could result in depletion of this cell subset in the peripheral blood of patients with MCTD.

Related Results

Association of T lymphocytes level and clinical severity in patients of COVID-19 in Shenzhen China
Association of T lymphocytes level and clinical severity in patients of COVID-19 in Shenzhen China
To explore the correlation between T lymphocytes and clinical severity in patients of COVID-19. A total of 183 COVID-19 patients were recruited in Shenzhen Third People’s Hospital ...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Unresponsiveness of CD4−8+/− thymocytes to lectin stimulation in LEC mutant rats
Unresponsiveness of CD4−8+/− thymocytes to lectin stimulation in LEC mutant rats
A mutant strain of rat, LEC, shows a novel arrest of T‐cell maturation from CD4+8+ to CD4+8−, but not to CD4−8+ cells in the thymus. The responsible mutant locus is designated the ...
Hubungan Hitung CD4 dengan Infeksi Cryptosporidium pada Pasien HIV AIDS
Hubungan Hitung CD4 dengan Infeksi Cryptosporidium pada Pasien HIV AIDS
Abstract. Human immunodeficiency virus (HIV) is a virus that can attack CD4 lymphocytes and cause immune cell death, resulting in severe immune deficiency in infected individuals. ...
Altered Thymic and Peripheral T-Lymphocyte Repertoire Preceding Onset of Diabetes in NOD Mice
Altered Thymic and Peripheral T-Lymphocyte Repertoire Preceding Onset of Diabetes in NOD Mice
Insulitis occurs by 5 wk of age in all NOD mice. However, diabetes is detectable only after 3–5 mo of age and only in ∼50% of females and 10% of males in our colony. Therefore, it ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top